title: Effects of oral androstenedione on steroid metabolism in liver of pregnant and non-pregnant female rats.
abstract: It is unknown whether androstenedione, a steroidal dietary supplement taken to enhance athletic performance, can affect physiological hormone levels by altering liver enzyme activities that metabolize steroid hormones. Altered hormone levels could be especially devastating during pregnancy. Mature female rats were gavaged with 0, 5, 30 or 60 mg/kg/day androstenedione beginning two weeks prior to mating and continuing through gestation day 19. Non-pregnant female rats were gavaged over the same time frame with 0 or 60 mg/kg/day androstenedione. Livers were removed from dams on gestation day 20 and from non-pregnant rats after five weeks' treatment. Liver microsomes were incubated with 200 microM testosterone, and the reaction products were isolated and analyzed by HPLC. In pregnant rats, formation of 6alpha-, 15beta-, 7alpha-, 16beta-, and 2beta-hydroxytestosterone was increased significantly vs. control at the highest dose level only. Formation of 6beta-hydroxytestosterone increased significantly at both the 30 and 60 mg/kg/day dose levels. In non-pregnant rats, 60 mg/kg/day androstenedione significantly increased formation of 15beta-, 6beta-, 16beta-, and 2beta-hydroxytestosterone. The data suggest that high oral doses of androstenedione can induce some female rat liver cytochromes P450 that metabolize steroid hormones and that the response to androstenedione does not differ between pregnant and non-pregnant female rats.
authors.affiliation: US FDA, Center for Food Safety and Applied Nutrition, Office of Applied Research and Safety Assessment, 8301 Muirkirk Road, Laurel, MD 20708, USA. tflynn@cfsan.fda.gov
authors.forename: T J
authors.initials: TJ
authors.lastname: Flynn
authors.forename: P P
authors.initials: PP
authors.lastname: Sapienza
authors.forename: P W
authors.initials: PW
authors.lastname: Wiesenfeld
authors.forename: I A
authors.initials: IA
authors.lastname: Ross
authors.forename: S
authors.initials: S
authors.lastname: Sahu
authors.forename: C S
authors.initials: CS
authors.lastname: Kim
authors.forename: M W
authors.initials: MW
authors.lastname: O'Donnell
authors.forename: T F X
authors.initials: TF
authors.lastname: Collins
authors.forename: R L
authors.initials: RL
authors.lastname: Sprando
mesh_terms: D000284:Administration, Oral; D000735:Androstenedione / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D003577:Cytochrome P-450 Enzyme System / Q000494:pharmacology; D005260:Female; D008099:Liver / Q000187:drug effects / Q000502:physiology; D011247:Pregnancy; D051381:Rats; D013256:Steroids / Q000378:metabolism*
chemical_list: D013256:Steroids; D000735:Androstenedione; D003577:Cytochrome P-450 Enzyme System